Trials / Unknown
UnknownNCT04525677
Gut Microbiome Dysbiosis in Sepsis-induced Coagulopathy
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
In the diagnosis and treatment of patients with sepsis, through routine stool testing and dynamic testing of coagulation function, we found that patients often have stools that are not formed, the proportion of main fecal bacteria is imbalanced, the level of blood bacterial toxins rises, and the abnormal coagulation status indicate the gut microbiome dysbiosis may play an important regulatory role in abnormal blood coagulation in patients with sepsis. Therefore, we propose that the gut microbiome dysbiosis is involved in sepsis-induced coagulopathy. This project intends to prospectively observe the changes in gut microbiome dysbiosis and blood coagulation function in patients with sepsis before and after treatment, and explore whether the changes in gut microbiome dysbiosis promote the development of sepsis through coagulation disorders, provide new research perspectives for diagnosis and treatment for sepsis.
Conditions
Timeline
- Start date
- 2020-07-15
- Primary completion
- 2021-07-15
- Completion
- 2021-07-15
- First posted
- 2020-08-25
- Last updated
- 2020-08-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04525677. Inclusion in this directory is not an endorsement.